申请人:——
公开号:US20020177594A1
公开(公告)日:2002-11-28
Compounds having the formula
1
or therapeutically acceptable salts thereof, are histone deacetylase (HDAC) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
具有以下化学式的化合物或其治疗上可接受的盐是组蛋白去乙酰化酶(HDAC)抑制剂。本文揭示了该化合物的制备、含有该化合物的组合物以及使用该化合物治疗疾病的方法。